跳至主要内容
临床试验/CTRI/2025/10/096105
CTRI/2025/10/096105尚未招募2 期

Comparing the effect of Transcranial direct current stimulation versus Transauricular vagus nerve stimulation on depressive symptoms in cancer patients undergoing radiation therapy- A Randomised Clinical Trial

Gayatri Govindankutty Marar1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2025年10月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
22
试验地点
1
主要终点
PHQ-9 scale is used to assess the depression and is assessed post intervention

研究概览

简要总结

This study focuses on addressing the high prevalence of depression in cancer patients receiving radiotherapy, which negatively affects their quality of life, treatment adherence, and outcomes. Since pharmacological options may add side effects in patients already on multiple medications, this study explores two non-invasive neuromodulation techniques—tDCS and taVNS—as safer alternatives. Using a randomized clinical trial design with 22 participants, patients will be assigned to receive either tDCS or taVNS along with conventional physiotherapy for two weeks, and outcomes will be assessed using PHQ-9, Fatigue severity scale, and EORTC QLQ-C30 scales. The aim is to compare the effectiveness of tDCS and taVNS in reducing depressive symptoms, fatigue, and improving quality of life in this patient group.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
40.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • 1.Participant diagnosed with cancer who are in the age group of 40 to 80 years of both genders.
  • 2.Participants willing to participate.
  • Participants with beck depression inventory more than 13.

排除标准

  • 1.Participants having any metal implants.
  • 2.Participants who are undergoing any forms of psychotherapy.
  • 3.Participants having history of uncontrolled epilepsy.
  • 4.Participants having pacemaker.
  • 6.Participants with cardiovascular risk or unstable cardiac disease.
  • 7.Participants with unstable medical conditions.
  • 8.Participants with active skin disease at electrode sites.

结局指标

主要结局

PHQ-9 scale is used to assess the depression and is assessed post intervention

时间窗: baseline and at 2 weeks

次要结局

  • fatigue severity scale is used to assess fatigue level of the patient(baseline & at 2 weeks)
  • EORTC QOL-C30 scale is used to assess the quality of life(baseline & at 2 weeks)

研究者

发起方
Gayatri Govindankutty Marar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Gayatri Govindankutty Marar

KLE Institute of Higher Education and Research Center

研究点 (1)

Loading locations...

相似试验